[Abdalla, A. A. R. K., Mohamed, A. M. A. (2014). Prevalence of extended spectrum β-lactamase producing Klebsiella pneumonia in clinical isolates. Jundishapur J. Microbiol., 7, 1-5.]Search in Google Scholar
[Anonymous (2013). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_v1.0_20131211.pdf (acessed 19.06.2016).]Search in Google Scholar
[Anonymous (2015). WHO. International statistical classification of diseases and related health problems. ICD-10 Version. Available at: http://apps.who.int/classifications/icd10/browse/2015/en (accessed 19.06.2016).]Search in Google Scholar
[Concepts, C., Peleg, A. Y., Hooper, D. C. (2010). Hospital-acquired infections due to gram-negative bacteria. New Engl. J. Med., 362, 1804-1813.10.1056/NEJMra0904124310749920463340]Search in Google Scholar
[Du, B., An, Y., Kang, Y., Yu, X., Zhao, M., Ma, X., Ai, Y., Xu, Y., Wang, Y., Qian, C., Wu, D., Sun, R., Li, S., Hu, Z., Cao, X., Zhou, F., Jiang, L., Lin, J., Chen, E., Qin, T., He, Z., Zhou, L. (2013). Characteristics of critically ill patients in ICUs in mainland China. Crit. Care Med., 41, 84-92.10.1097/CCM.0b013e31826a408223222268]Search in Google Scholar
[Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., Stratchounski, L. (2003). Prevalence and molecular epidemiology of CTX-M extended-spectrumlactamase- producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents. Chemother., 47, 3724-3732.10.1128/AAC.47.12.3724-3732.200329619014638473]Search in Google Scholar
[Kim, B. N., Woo, J. H., Kim, M. N., Ryu, J., Kim, Y. S. (2002). Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J. Hosp. Infect., 52, 99-106.10.1053/jhin.2002.128812392901]Search in Google Scholar
[Mayr, V. D., Dünser, M. W., Greil, V., Jochberger, S., Luckner, G., Ulmer, H., Friesenecker, B. E., Takala, J., Hasibeder, W. R. (2006). Causes of death and determinants of outcome in critically ill patients. Crit. Care, 10 (6), R154.]Search in Google Scholar
[Mehrgan, H., Rahbar, M., Arab-halvaii, Z. (2010). High prevalence of extended- spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran. Iran J. Infect. Dev. Ctries., 4 (3), 132-138.]Search in Google Scholar
[Nüesch-Inderbinen, M. T., Hächler, H., Kayser, F. H. (1996). Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis., 15, 398-402.10.1007/BF016900978793399]Search in Google Scholar
[Peralta, G., Lamelo, M., Alvarez-García, P., Velasco, M., Delgado, A., Horcajada, J. P., Montero, M., Pia Roiz, M., Farinas, M. C., Alonso, J., Martinez, L. M., Gutierrez-Macias, A., Alava, J. A., Rodríguez, A., Fleites, A., Navarro, V., Sirvent, E., Capdevila, J. A. (2012). Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect. Dis., 12, 245-251.10.1186/1471-2334-12-245351970123038999]Search in Google Scholar
[Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., Kamal, M. A. (2015). Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. Biol. Sci., 22, 90-101.10.1016/j.sjbs.2014.08.002428162225561890]Search in Google Scholar
[Skippen, I., Shemko, M., Turton, J., Kaufmann, M. E., Palmer, C., Shetty, N. (2006). Epidemiology of infections caused by extended-spectrum _-lactamase-producing Escherichia coli and Klebsiella spp.: A nested case-control study from a tertiary hospital in London. J. Hosp. Infect., 64, 115-23.10.1016/j.jhin.2006.05.01016859810]Search in Google Scholar
[Spanu, T., Luzzaro, F., Perilli, M., Amicosante, G., Toniolo, A., Fadda, G. (2002). Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob. Agents Chemother., 46, 196-202.10.1128/AAC.46.1.196-202.200212698311751134]Search in Google Scholar
[Thu Trang, N. H., Thieu Nga, T. V., Campbell, J. I., Hiep, N. T., Farrar, J., Baker, S., Duy, P. T. (2013). The characterization of ESBL genes in Escherichia coli and Klebsiella pneumoniae causing nosocomial infections in Vietnam. J. Infect. Dev. Ctries., 7, 922-928.10.3855/jidc.293824334938]Search in Google Scholar
[Wu, T. L., Siu, L. K., Su, L. H., Lauderdale, T. L., Lin, F. M., Leu, H. S., Lin, T. Y., Ho, M. (2001). Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J. Antimicrob. Chemother., 47, 755-761.10.1093/jac/47.6.75511389107]Search in Google Scholar
[Wu, Y. H., Chen, P. L., Hung, Y. P., Ko, W. C. (2014). Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J. Microbiol. Immunol. Infect., 47, 197-203.10.1016/j.jmii.2012.09.00123063776]Search in Google Scholar